We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$224B
AUM Growth
+$21B
Cap. Flow
+$7.48B
Cap. Flow %
3.33%
Top 10 Hldgs %
24.57%
Holding
10,190
New
1,427
Increased
4,227
Reduced
3,278
Closed
1,044

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$798M
2
T icon
AT&T
T
+$527M
3
MCHP icon
Microchip Technology
MCHP
+$472M
4
NFLX icon
Netflix
NFLX
+$446M
5
PNC icon
PNC Financial Services
PNC
+$444M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$694M
2
KEY icon
KeyCorp
KEY
+$401M
3
DE icon
Deere & Co
DE
+$322M
4
CSX icon
CSX Corp
CSX
+$318M
5
NXPI icon
NXP Semiconductors
NXPI
+$314M

Sector Composition

Rank Sector Weight
1 Financials 5.93%
2 Technology 4.66%
3 Healthcare 4.45%
4 Industrials 4.14%
5 Consumer Discretionary 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FPI
8451
PUT
Farmland Partners
FPI
$425M
$90K ﹤0.01%
+13,500
New +$92.7K
LSCC icon
8452
CALL
Lattice Semiconductor
LSCC
$18.4B
$90K ﹤0.01%
+11,200
New +$82.8K
NL icon
8453
NLI Holdings
NL
$329M
$90K ﹤0.01%
15,060
-3,690
-20% -$29.4K
DSKE
8454
PUT
DELISTED
Daseke, Inc. Common Stock
DSKE
$90K ﹤0.01%
11,200
-10,000
-47% -$89.4K
NBEV
8455
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$90K ﹤0.01%
+16,825
New +$38.1K
CALA
8456
PUT
DELISTED
Calithera Biosciences, Inc
CALA
$89K ﹤0.01%
845
-890
-51% -$84.7K
AST
8457
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$89K ﹤0.01%
68,717
+34,174
+99% +$53.1K
GFI icon
8458
CALL
Gold Fields
GFI
$35.4B
$88K ﹤0.01%
36,300
+6,700
+23% +$20.1K
GORO icon
8459
PUT
Goldgroup Mining Inc.
GORO
$211M
$88K ﹤0.01%
+17,200
New +$99.5K
QUIK icon
8460
QuickLogic
QUIK
$230M
$88K ﹤0.01%
6,304
+4,147
+192% +$62.9K
FNJN
8461
DELISTED
Finjan Holdings, Inc.
FNJN
$88K ﹤0.01%
+20,494
New +$85.8K
SJT
8462
San Juan Basin Royalty Trust
SJT
$131M
$87K ﹤0.01%
+17,553
New +$101K
NYMX
8463
DELISTED
Nymox Pharmaceutical Corp
NYMX
$87K ﹤0.01%
35,466
-18,259
-34% -$53.9K
PER
8464
CALL
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$87K ﹤0.01%
+32,800
New +$86.7K
PFSW
8465
PUT
DELISTED
PFSweb, Inc.
PFSW
$87K ﹤0.01%
+11,800
New +$106K
AVDL
8466
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
$86K ﹤0.01%
19,500
+7,100
+57% +$38.3K
MVIS icon
8467
CALL
Microvision
MVIS
$89.7M
$86K ﹤0.01%
4,720
+1,673
+55% +$26.2K
VRN
8468
CALL
DELISTED
Veren
VRN
$86K ﹤0.01%
13,600
-6,000
-31% -$39.5K
CRHM
8469
DELISTED
CRH Medical Corporation
CRHM
$86K ﹤0.01%
21,770
+4,471
+26% +$16.5K
RBS.PRS.CL
8470
DELISTED
The Royal Bank Of Scotland Group
RBS.PRS.CL
0
GEVO icon
8471
Gevo
GEVO
$401M
$85K ﹤0.01%
+21,477
New +$85.2K
VVR icon
8472
Invesco Senior Income Trust
VVR
$457M
$85K ﹤0.01%
19,765
-1,161
-6% -$5.01K
ACHV icon
8473
Achieve Life Sciences
ACHV
$744M
$84K ﹤0.01%
+1,329
New +$84.1K
CARM
8474
CALL
DELISTED
Carisma Therapeutics
CARM
$84K ﹤0.01%
1,955
-70
-3% -$2.73K
EGY icon
8475
CALL
Vaalco Energy
EGY
$592M
$84K ﹤0.01%
30,900
+19,600
+173% +$51.6K

Similar funds

Citadel Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Citadel Advisors held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Citadel Advisors deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.

By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.

  • Citadel Advisors's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
  • Citadel Advisors added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
  • Citadel Advisors's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
  • Citadel Advisors fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
  • Citadel Advisors's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
  • Citadel Advisors opened 1,427 new positions and closed 1,044 in Q3 2018.
  • Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $224B.

Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.